No Data
No Data
Despite Lower Earnings Than a Year Ago, Changjiang Securities (SZSE:000783) Investors Are up 21% Since Then
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Delivers Shareholders Notable 21% CAGR Over 3 Years, Surging 6.7% in the Last Week Alone
Yichang HEC Changjiang Pharmaceutical's Merger Offeror Agreed to License-out Product for $938 Million
We Think That There Are Some Issues For Chongqing Changjiang River Moulding Material (Group) (SZSE:001296) Beyond Its Promising Earnings
YiChang HEC ChangJiang's Privatization Progress Update
The Total Return for Changjiang Publishing & MediaLtd (SHSE:600757) Investors Has Risen Faster Than Earnings Growth Over the Last Three Years
No Data
No Data